United Capital Management of KS’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-40,644
Closed -$1.51M 106
2019
Q4
$1.51M Buy
40,644
+4,442
+12% +$158K 0.96% 39
2019
Q3
$1.23M Buy
36,202
+1,911
+6% +$69.5K 0.9% 41
2019
Q2
$1.42M Buy
34,291
+226
+0.7% +$8.97K 1.08% 33
2019
Q1
$1.27M Buy
34,065
+1,302
+4% +$52.1K 1% 34
2018
Q4
$1.36M Buy
32,763
+781
+2% +$32.4K 1.26% 26
2018
Q3
$1.31M Buy
+31,982
New +$1.23M 1.06% 31

Other funds holding PFE

United Capital Management of KS's PFE Position: Q1 2020 in Review

United Capital Management of KS sold out of Pfizer (PFE) in Q1 2020, closing a stake of 40,644 shares — an estimated $1.51M sold.

United Capital Management of KS first reported a position in PFE in Q3 2018 and held it in 6 quarters. The position peaked at $1.51M in Q4 2019. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • United Capital Management of KS reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • United Capital Management of KS sold 40,644 Pfizer shares in Q1 2020, an estimated $1.51M.
  • United Capital Management of KS first reported a position in Pfizer in Q3 2018 and held it in 6 quarters.
  • United Capital Management of KS's Pfizer position peaked at $1.51M in Q4 2019.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on United Capital Management of KS's 13F filing for Q1 2020, filed 4 May 2020.